Chinese Guidelines for Clinical Diagnosis,Treatment,and Management of Cirrhosis(2025)
摘要
The Chinese Society of Hepatology of the Chinese Medical Association has invited experts in relevant fields to revise and rename the 2019“Chinese Guidelines on the Management of Liver Cirrhosis”to“Chinese Guidelines for Clinical Diagnosis,Treatment,and Management of Cirrhosis(2025)”.These updated guidelines are aimed at providing recommendations for the clinical diagnosis and management of liver cirrhosis across the compensated,decompensated,and recompensated stages,as well as guidance on cirrhosis reversal and associated complications.
基金
Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project(2025ZD01906300&2025ZD01906303).
-
1Xing Liu,Fengyang Chen,Zhaozhe Liu,Mingyu Duan,Ye Gu,Xuan Liang,Xiaofeng Wu,Cheng Lv,Xinyue Li,Jiamin Qian,Meiyuxi Li,Linge Zhang,Tianyue Chen,Yan Wang,Guoliang Chen.A Novel Probe Technology for Detecting Native Albumin Activity as a Biomarker in Patients with Hepatitis B-related Cirrhosis and Hepatocellular Carcinoma and Its Clinical Applications[J].Future Integrative Medicine,2024,3(3):172-182.
-
2Donghyun Ko,Do Han Kim,Pojsakorn Danpanichkul,Masahito Nakano,Chitchai Rattananukrom,Karn Wijarnpreecha,Cheng Han Ng,Mark D.Muthiah.Liver cirrhosis in metabolic dysfunction-associated steatohepatitis[J].Gastroenterology Report,2025,13(1):569-576.
-
3Siyu Jiang,Sanqiang Wang,Jinsheng Guo,Liyuan Ni,Yingjie Ai,Sitao Ye,Ye Fang,Xiaoquan Huang,Shiyao Chen.Predictive Value of Coagulation FactorⅧ and Protein C Levels for Further Decompensated Events in Patients With Decompensated Cirrhosis[J].Portal Hypertension & Cirrhosis,2025,4(4):201-210.
-
4Zia Ur Rahman,Nigar Ali,Dragan Pamucar,Imtiaz Ahmad,Haci Mehmet Baskonus,Naseer Ul Haq,Zeeshan Ali.Modeling Hepatitis B and Alcohol Effects on Liver Cirrhosis Progression[J].Computer Modeling in Engineering & Sciences,2026,146(1):954-988.
-
5张思齐,许红梅.儿童肝硬化病因研究进展[J].临床医学进展,2026,16(2):31-38.
-
6Xuefeng Luo,Guangchuan Wang,Li Yang,Virginia Hernandez-Gea.Future research direction of portal hypertension based on Baveno Ⅶ[J].Chinese Medical Journal,2025,138(18):2268-2282.
-
7Hiroki Nishikawa,Soo Ki Kim,Akira Asai.Pharmacotherapy for Cirrhosis in Japan[J].Portal Hypertension & Cirrhosis,2025,4(2):111-119.
-
8Hong-Li Liu,Xing Liu,Xi-Xuan Wang,Yu-Hang Weng,Qing-Fang Xiong,Yan-Dan Zhong,Hui Zhou,Du-Xian Liu,Chun Lv,Yong-Feng Yang.Giant Liver Nodules in Alagille Syndrome:Diagnostic Insights From Imaging and Biopsy[J].Portal Hypertension & Cirrhosis,2025,4(3):196-199.
-
9Yu Chen,Tao Han,Zhongping Duan,Severe Liver Disease and Artificial Liver Group,Chinese Society of Hepatology,Chinese Medical Association,Nutrition and Regeneration in End-Stage Liver Disease Group,Chinese Society of Hepatology,Chinese Medical Association.Guidelines for the diagnosis and treatment of acute-on-chronic liver failure(2025)[J].Chinese Medical Journal,2025,138(24):3218-3221.
-
10Mengqin Zhou,Li Liu.Observation and Study on the Therapeutic Effect of Diuretics in Patients with Cirrhotic Ascites[J].Journal of Clinical and Nursing Research,2026,10(1):116-122.
